Vir Biotechnology, Inc. Stock Analysis & AI Score
Vir Biotechnology, Inc. (VIR) has an ST Score of 55.7 (B-), driven by its Forecast (A) and held back by its Growth (C-). Analysts rate it Buy with a $25.00 price target (+133.2% upside).
Composite rating from 8 factors. Tap a factor to see the metrics behind its grade.
Company Information
| Employees | — |
| CEO | — |
| Sector | Healthcare |
| Industry | Biotechnology |
| IPO Date | — |
| Website | — |
| Country | — |
| Exchange | NASDAQ |
SEC Filings
Annual Report (10-K)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
Quarterly Report (10-Q)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
ST Score
Vir Biotechnology, Inc. (VIR) has an ST Score of 55.7 (B-), driven by its Forecast (A) and held back by its Growth (C-). Analysts rate it Buy with a $25.00 price target (+133.2% upside).
- Strongest
- ForecastA
- Weakest
- GrowthC-
All factor grades
- ForecastA
- MomentumA-
- ValuationB+
- ProfitabilityB+
- Financial StrengthC-
- GrowthC-
- Piotroski2/9
Contact
VIR stock: frequently asked questions
What is VIR's ST Score?
Vir Biotechnology, Inc. (VIR) has an ST Score of 55.7 (B-), on our 0–100 scale where higher is stronger. The ST Score combines eight factor grades — valuation, profitability, financial strength, momentum, growth, forecast, sentiment and Piotroski — into a single A+ to F rating.
Is VIR a buy, hold, or sell?
Analysts rate VIR a Buy, with a price target of $25.00 (+133.2% vs the current price). Our ST Score grades it B- (55.7/100). The ST Score is a data-driven signal, not a recommendation.
What are VIR's factor grades?
Valuation B+, Profitability B+, Financial Strength C-, Momentum A-, Growth C-, Forecast A.
What is VIR's valuation grade?
Vir Biotechnology, Inc. (VIR) earns a valuation grade of B+, measured against Biotechnology peers. The valuation factor looks at multiples such as P/E, P/S, P/B, EV/EBITDA and free cash flow yield.
What is VIR's growth grade?
Vir Biotechnology, Inc. (VIR) earns a growth grade of C-, measured against Biotechnology peers. The growth factor looks at revenue, earnings and cash flow growth over recent quarters and years.
What is VIR's profitability grade?
Vir Biotechnology, Inc. (VIR) earns a profitability grade of B+, measured against Biotechnology peers. The profitability factor looks at margins and returns such as gross margin, net margin, ROE and ROIC.
What is VIR's financial strength grade?
Vir Biotechnology, Inc. (VIR) earns a financial strength grade of C-, measured against Biotechnology peers. The financial strength factor looks at debt levels, liquidity and coverage ratios.
What is the analyst price target for VIR?
The average analyst price target for Vir Biotechnology, Inc. (VIR) is $25.00 from 12 analysts, which is +133.2% versus the recent price of $10.72.
What is VIR's Piotroski score?
Vir Biotechnology, Inc. (VIR) has a Piotroski F-Score of 2 out of 9. The Piotroski score checks nine accounting signals covering profitability, leverage and operating efficiency; scores of 8–9 are considered strong and 0–2 weak.